Corsair Capital Management »

Iovance Biotherapeutics shares owned by Corsair Capital Management

Quarter-by-quarter ownership of Iovance Biotherapeutics (IOVA) shares owned by Corsair Capital Management from 13F filings

Historical chart of Corsair Capital Management investment in Iovance Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Iovance Biotherapeutics held by Corsair Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Iovance Biotherapeutics by Corsair Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.2M 350k 3.51
2025-12-31 $819k 300k 2.73

More positions owned by Corsair Capital Management

Gpgi Com Cl A (GPGI)
Vertiv Holdings Com Cl A (VRT)
Laureate Ed Common Stock (LAUR)
Resolute Hldgs Mgmt (RHLD)
Api Group Corp Com Stk (APG)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Limbach Hldgs (LMB)
Spx Corp (SPXC)
Mirion Technologies Com Cl A (MIR)
Aon Shs Cl A (AON)
Alphabet Cap Stk Cl A (GOOGL)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Microsoft Corporation (MSFT)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Iren Ordinary Shares (IREN)

View all positions for Corsair Capital Management

Top funds holding Iovance Biotherapeutics

BlackRock
MHR Fund Management
Vanguard Group
State Street Corporation
Vanguard Capital Management
Two Sigma Investments
Vanguard Portfolio Management
Millennium Management
Goldman Sachs Group
Geode Capital Management
Invenomic Capital Management
Bank of America Corporation
D. E. Shaw & Co
Susquehanna International
Palo Alto Investors

View all funds holding Iovance Biotherapeutics